Second Generation® FIT is a five minute, in-office colon cancer screening test, with no diet or medicine restrictions. It is recognized as the gold standard for Colorectal Cancer Detection by the American College of Gastroenterology, and an approved colorectal cancer screening method by the U.S. Joint Preventative Task Force, the Center for Disease Control, and the American Cancer Society. The test may also be sent home and mailed back. NAFDAC Approved.
Resources & Documentation
Scientific Data & FIT Reviews
Since 2008 the FIT test has been recommended as a replacement for guaiac (Hemmocult®) cards, which the American College of Gastroenterology states should be abandoned as a method for CRC screening. The Fecal Immunochemical Test has been studied extensively over the last decade, and every major authoritative body recommends FIT as a Colon Cancer Screening Test. Physicians notably appreciate:
- Ease of Use
- Lack of Diet/Medicine Restrictions
- A Single Sample (vs. 2, or 3) with other tests
- Profitability From Performing the Test
Second Generation FIT® is designed to detect hemoglobin levels - a biomarker for Colorectal Cancer, Diverticulitis, Crohn's Disease, IBD and IBS - at 50 ng/mL in a spontaneously passed stool. Studies have shown that the overall sensitivity for occult (hidden) blood is 98% while the specificity is 96%; leaving the accuracy of Second Generation FIT® at 97%. The test has a two year shelf life from the date of manufacture and can be stored at room temperature. The test is CLIA waived CPT CODE: 82274QW and/or G0328QW ($22.23) national average reimbursement.